Statistics
Publications
23
Citations
2K
H-Index
20
Active since
1998
Masanori Okaniwa is an author at Takeda (Japan) specializing in drug discovery, drug design, and pharmacology.
Publications per year
1998–2022
23
23
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Vanessa Rodrik-Outmezguine, Masanori Okaniwa, Zhan Yao et al. · Nature · 2016 · 482 citations
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma
Qi-Wen Fan, Ozlem Aksoy, Robyn A. Wong et al. · Cancer Cell · 2017 · 182 citations
Medicine, Cancer Biology, Oncology +14
1–5 of 23